Article Versions Notes

Sachkova AA, Andreeva DV, Tikhomirov AS, Scherbakov AM, Salnikova DI, Sorokin DV, Bogdanov FB, Rysina YD, Shchekotikhin AE, Shchegravina ES, et al. Design, Synthesis and In Vitro Investigation of Cabozantinib-Based PROTACs to Target c-Met Kinase. Pharmaceutics. 2022; 14(12):2829. https://doi.org/10.3390/pharmaceutics14122829

Sachkova, Anastasia A., Daria V. Andreeva, Alexander S. Tikhomirov, Alexander M. Scherbakov, Diana I. Salnikova, Danila V. Sorokin, Fedor B. Bogdanov, Yulia D. Rysina, Andrey E. Shchekotikhin, Ekaterina S. Shchegravina, and et al. 2022. "Design, Synthesis and In Vitro Investigation of Cabozantinib-Based PROTACs to Target c-Met Kinase" Pharmaceutics 14, no. 12: 2829. https://doi.org/10.3390/pharmaceutics14122829

Sachkova, A. A., Andreeva, D. V., Tikhomirov, A. S., Scherbakov, A. M., Salnikova, D. I., Sorokin, D. V., Bogdanov, F. B., Rysina, Y. D., Shchekotikhin, A. E., Shchegravina, E. S., & Fedorov, A. Y. (2022). Design, Synthesis and In Vitro Investigation of Cabozantinib-Based PROTACs to Target c-Met Kinase. Pharmaceutics, 14(12), 2829. https://doi.org/10.3390/pharmaceutics14122829